What Lies Ahead for Software Stocks & ETFs in AI Agent Economy?

Gartner estimates agentic AI could put up to $234 billion, or roughly 20%, of enterprise SaaS application spending at risk by 2030 by reducing demand for traditional seat-based software licenses. Software stocks have rebounded from an AI-driven selloff—the Dow Jones U.S. Software Index recovered 42.5% from its April 2026 low, while IGV and XSW gained more than 26% and 34%, respectively, over six months—but face renewed disruption risk. Offsetting this, Salesforce's Agentforce and Data 360 ARR reached nearly $3.9 billion, up more than 210% year over year, while Microsoft surpassed 30 million paid Microsoft 365 Copilot seats, supporting a selective AI-enabled software growth thesis.

Analysis

The investable distinction is not “AI exposure” but pricing power over the agent workflow. Platforms owning proprietary workflow data, permissions and system-of-record status can charge incremental consumption or outcome fees; horizontal collaboration and point-product vendors face the opposite risk, as agents compress clicks, seats and switching costs. This favors CRM and NOW over the equal-weight software tail in XSW, while SNOW benefits if agent workloads materially increase data consumption rather than merely shift existing queries to lower-margin inference.

Near term (next 1-3 months), the sector’s rebound leaves little room for vague AI narratives: earnings must show paid-agent attach rates, net revenue retention stabilization and incremental gross-margin durability. The key underappreciated risk is that agent revenue can be economically dilutive at launch—model inference, cloud spend and customer-success costs may rise ahead of pricing—so headline AI ARR without disclosure of consumption margins should not command a multiple re-rating. MSFT is relatively insulated because it can monetize both the application layer and Azure capacity, but Copilot adoption that cannibalizes premium M365 bundles would weaken the thesis.

Over 6-18 months, agent interoperability could shift value away from front-end SaaS interfaces toward identity, data governance and orchestration. That creates a second-order beneficiary in MSFT and potentially CRM/NOW, whose embedded enterprise controls are costly to replicate; it is adverse to vendors with limited proprietary data moats. The contrarian view is that the market is still treating all software as equally threatened, but the more immediate risk is not seat elimination—it is a transition to variable revenue that raises forecasting uncertainty and compresses revenue-quality multiples.

Key Decisions for Investors

• Initiate a 3-6 month pair: long CRM / short XSW. CRM has the clearest route to monetize workflow ownership, while XSW provides exposure to smaller, more seat-dependent vendors with less ability to absorb inference costs. Target 10-15% relative upside; exit if CRM's paid-agent growth decelerates for two consecutive quarters or subscription gross margin falls materially.
• Maintain MSFT as the core large-cap software exposure rather than broad IGV: Azure provides a hedge against application-layer disruption. Add only following evidence that Copilot/agent monetization lifts commercial remaining-performance-obligation or Azure consumption without a corresponding decline in M365 revenue per user; reassess on sub-consensus cloud growth or rising AI capex without monetization.
• Trade SNOW tactically long into the next earnings only if management quantifies AI-driven incremental consumption and product gross-margin impact. A positive setup requires consumption growth reacceleration beyond easy comparisons; absent margin disclosure, avoid chasing because the valuation is highly sensitive to any inference-cost surprise.
• Avoid adding broad IGV/XSW beta after the recovery. Use an IGV put spread 3-6 months out as a hedge against a software-wide de-rating if upcoming earnings reveal flat seat growth, weaker net retention, or agent products displacing legacy subscription revenue rather than expanding total spend.